HIV Basics: The History and Current State of the Epidemic by Hatch, Steven C.
University of Massachusetts Medical School 
eScholarship@UMMS 
PEER Liberia Project UMass Medical School Collaborations in Liberia 
2020-09-24 
HIV Basics: The History and Current State of the Epidemic 
Steven C. Hatch 
University of Massachusetts Medical School 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/liberia_peer 
 Part of the Family Medicine Commons, Infectious Disease Commons, Medical Education Commons, 
and the Virus Diseases Commons 
Repository Citation 
Hatch SC. (2020). HIV Basics: The History and Current State of the Epidemic. PEER Liberia Project. 
https://doi.org/10.13028/z9we-zd37. Retrieved from https://escholarship.umassmed.edu/liberia_peer/56 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in PEER Liberia Project 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
HIV Basics: the History and 
Current State of the Epidemic
Steven Hatch, MD
USAID PEER/Liberia ID Lecture Series
24 September 2020
Goals
 Provide HIV in brief historical context
 Illustrate life cycle of HIV and demonstrate 
effects of various drug classes on disruption of 
life cycle
 Discuss basic treatment strategies













HIV-1 P from gorillas
Maybe HIV-1 O too
MOST CASES OF HIV ARE 
HIV-1 M (minimal clinical 
significance)
Late 1800s - 1981
 HIV spreads ~1920-1950 along the Congo river: 
Brazzaville to Leopoldville (now Kinshasa) 
 Haitian professionals training in Congo in mid-1960s 
return
 From there, virus jumps to US ~1969 
 See Faria N et al, “The early spread and epidemic 
ignition of HIV-1 in human populations,” Science 346 
(6205): 56-61.
 By 1960s, African doctors note rise in OIs and wasting in 




“And The Band Played On”
 Initially called “GRID”—Gay Related Immune 
Syndrome
 Mult causal etiologies espoused, including 
“poppers,” gay lifestyle; several scientists 
understood quickly that it was likely STV
 Also known as “4H Syndrome”—Homosexuals, 
Hemophiliacs, Haitians, and Heroin users
 AIDS coined July 1982
1980s con’t
 1984: virus is identified (Gallo/Montagnier)
 1985: China reports AIDS; last major 
populated region on earth to do so
 1987: AZT approved
 By end of 1980s, ~8 million people with 
HIV infection
 For more: And The Band Played On, 
Randy Shilts of San Francisco Chronicle 
(USA epidemic)





2016 Estimated Prevalence ~37 M
~700,000 
deaths/year
Fortunately it’s not all bad news

What does infection look like
Time











Inverse correlation between viral load & CD4 decline
Untreated HIV is a train heading toward a cliff:
CD4 count = distance to the cliff (immune collapse);
Viral Load = speed of the train
Fauci AS, Desrosiers RC 1997. Pathogenesis of HIV and SIV. In Retroviruses (ed. Coffin 
JM, et al. ), pp. 587–635 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

Viral replication, kinetics & 
resistance
HIV Replication and Mutation
(highly simplified)
 Suppose 104 virions/mL (ie VL = 10,000)
 RNA Pol error rate ~1 every 104 nucleotides
 HIV genome is 104 ~nucleotides long
 HIV replication produces 108 virons/day
 Given replication k inetics, all possible 
point mutations can be produced each 








Principal Events in HIV Replication
One additional agent (enfuvirtide) blocks entry from a 































Treatment options as of 2020 by class
Reverse Transcriptase 







HIV Replication and Mutation,
reconsidered
 RNA Pol error rate ~1 every 104 nucleotides
 HIV replication produces 108 virons/day
 One “pressure point” (ie, active 
medication) is not enough; virus w ill 
develop resistance mutations almost 
immediately
 This is the reasoning behind HAART
HAART basics
 Basic strategy: pressure virus at three separate 
points
 2 nukes + integrase inhibitor (eg TDF/FTC + DTG), or
 2 nukes + protease inhibitor (eg TDF/FTC + DRV/r), or
 2 nukes + non-nuke (eg TDF/FTC + EFV—but this is 2nd line)
 OR:
 Truvada plus Dolutegravir;
 Truvada plus Atazanavir;
 Truvada plus Efavirenz (or in one pill as Atripla)
HAART basics con’t
 Integrase Inhibitors favored over Protease 
Inhibitors because of once-daily dosing/combo 
pills
 Must consider many variables when prescribing
 For example: Hep B status, VL >100K, HLA 
status, CKDz, psych illness, cirrhosis, QTc, TB on 
rif, osteoporosis, other
Selected HIV web resources










Lots of stuff to do.
Go and learn.
